Vnitr Lek 2019, 65(2):149-156 | DOI: 10.36290/vnl.2019.029

Anaphylactic symptoms and anaphylactic shock

Irena Krčmová*, Jakub Novosad
Ústav klinické imunologie a alergologie LF UK a FN Hradec Králové

Anaphylactic symptoms and anaphylactic shock are serious, rapidly developing and potentially fatal systemic reactions occurring after contact with the trigger, followed by release of a number of substances that affect vascular permeability, smooth muscle tone of blood vessels and bronchi with activation of the systemic inflammatory cascade. From a pathophysiological point of view, it can be an IgE-mediated immune response followed by massive release of biologically active mediators from mast cells and basophils (IgE dependent). If the mastocyt/basophil is degranulated via a direct IgE-free pathway, it is non-allergic (non-IgE dependent, anaphylactoid anaphylaxis). The diagnosis of anaphylaxis is determined on the basis of clinical criteria, taking into account the need to initiate therapy in a life-threatening condition without delay. Adrenaline is the first-line drug in the treatment of anaphylaxis and there is no contraindication to its use. Early provision of venous intake is essential for the patient to develop hypotension.

Keywords: anaphylaxis; IgE dependent anaphylaxis; non IgE dependent anaphylaxis; management of anaphylaxis

Received: November 22, 2018; Accepted: November 26, 2018; Published: February 1, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Krčmová I, Novosad J. Anaphylactic symptoms and anaphylactic shock. Vnitr Lek. 2019;65(2):149-156. doi: 10.36290/vnl.2019.029.
Download citation

References

  1. Muraro A, Roberts, G, Worm M et al. Anaphylaxis: guidelines from European Academy of Allergy and Clinical Immunology. Allergy 2014; 69(8): 1026-1045. Dostupné z DOI: <http://doi:10.1111/all.12437>. Go to original source... Go to PubMed...
  2. Petrů V. Chyby a omyly v diagnostice a léčbě anafylaxe. Postgrad Med 2017; 19(3): 285-290.
  3. Tanno LK, Ganem F, Demoly P et al. Undernotification of anaphylaxis deaths in Brazil due to difficult coding under the ICD-10. Allergy 2012; 67(6): 783-789. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1398-9995.2012.02829.x>. Go to original source... Go to PubMed...
  4. Panesar SS, Nwaru B, Hickstein L et al. The epidemiology of anaphylaxis in Europe: protocol for a systematic review. Clin Transl Allergy 2013; 3(1): 9. Dostupné z DOI: <http://dx.doi.org/10.1186/2045-7022-3-9>. Go to original source... Go to PubMed...
  5. Worm A, Moneret-Vautrin AM, Scherer K et al. First European data from the network of severe allergic reaction (NORA). Allergy 2014; 69(10): 1397-1404. Dostupné z DOI: <http://dx.doi.org/10.1111/all.12475>. Go to original source... Go to PubMed...
  6. Finkelman F, Khodoun M, Strait R. Human IgE-independent systemic anaphylaxis. J Allergy Clin Immunol 2016; 137(6): 1674-1680. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jaci.2016.02.015>. Go to original source... Go to PubMed...
  7. Petrů V, Krčmová I. Anafylaktická reakce. Maxdorf Jessenius: Praha 2006: 3-95. ISBN 80-7345-099-2.
  8. Krejsek J, Andrýs C, Krčmová I. Imunologie člověka. Garamon: Hradec Králové: 2016: 213-221. ISBN 978-80-86472-74-4.
  9. Mehr S, Liew WK, Tey D et al. Clinical predictors for biphasic reactions in children presenting with anaphylaxis. Clin Exp Allergy 2009; 39(9): 1390-1396. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1365-2222.2009.03276.x>. Go to original source... Go to PubMed...
  10. Park HJ, Kim SH. Factors associated with shock in anaphylaxis. Am J Emerg Med 2012; 30(9): 1674-1678. Dostupné z DOI: <http://dx.doi.org/10.1016/j.ajem.2012.01.015>. Go to original source... Go to PubMed...
  11. Simons FER, Clark S, Camargo CA Jr. Anaphylaxis in the community: learning from the survivors. J Allergy Clin Immunol 2009; 124(2): 301-306. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jaci.2009.03.050>. Go to original source... Go to PubMed...
  12. Soar J, Perkins GD, Abbas G et al. European Resuscitation Council Guidelines for Resuscitation 2010 Section 8. Cardiac arrest in special circumstances: electrolyte abnormalities, poisoning, drowning, accidental hypothermia, hyperthermia, asthma, anaphylaxis, cardiac surgery, trauma, pregnancy, electrocution. Resuscitation 2010; 81(10): 1400-1433. Dostupné z DOI: <http://dx.doi.org/10.1016/j.resuscitation.2010.08.015>. Go to original source... Go to PubMed...
  13. Bock SA, Munoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol 2007; 119(4): 1016-1018. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jaci.2006.12.622>. Go to original source... Go to PubMed...
  14. Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000; 30(8): 1144-1150. Go to original source... Go to PubMed...
  15. Braganza SC, Acworth JP, McKinnon DR et al. Paediatric emergency department anaphylaxis: different patterns from adults. Arch Dis Child 2006; 91(2): 159-163. Dostupné z DOI: <http://dx.doi.org/10.1136/adc.2004.069914>. Go to original source... Go to PubMed...
  16. Calvani M, Cardinale F, Martelli A et al. Risk factors for severe pediatric food anaphylaxis in Italy. Pediatr Allergy Immunol 2011; 22(8): 813-819. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1399-3038.2011.01200.x>. Go to original source... Go to PubMed...
  17. Gonzalez-Perez A, Aponte Z, Vidaurre CF et al. Anaphylaxis epidemiology in patients with and patients without asthma: a United Kingdom databas review. J Allergy Clin Immunol 2010; 125(5): 1098-1104. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jaci.2010.02.009>. Go to original source... Go to PubMed...
  18. Hamilton MJ, Hornick JL, Akin C et al. Mast cell activation syndrome: a newly recognized disorder with systemic clinical manifestations. J Allergy Clin Immunol 2011; 128(1): 147-152. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jaci.2011.04.037>. Go to original source... Go to PubMed...
  19. Moneret-Vautrin DA. Drugs as risk factors of food anaphylaxis in adults. Facteurs de risque d'anaphylaxie alimentaire severe Role confirme de certaines classes de medicaments. Med Sci (Paris) 2010; 26(8-9): 719-723. Dostupné z DOI: <http://dx.doi.org/10.1051/medsci/2010268-9719>. Go to original source... Go to PubMed...
  20. Niggemann B, Beyer K. Time for a new grading system for allergic reaction? Allergy 2016; 71(2): 135-136. Dostupné z DOI: <http://dx.doi.org/10.1111/all.12765>. Go to original source... Go to PubMed...
  21. De Schryver S, Halbrich M, Clarke A et al. Tryptase levels in children presenting with anaphylaxis. Temporal trends and associated factors. J Allergy Clin Immunol 2016; 137(4): 1138-1142. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jaci.2015.09.001>. Go to original source... Go to PubMed...
  22. Noimark L, Wales J, Du Toit G et al. The use of adrenaline autoinjectors by children and teenagers. Clin Exp Allergy 2012; 42(2): 284-292. Dostupné z DOI: <http://doi:10.1111/j.1365-2222.2011.03912.x>. Go to original source... Go to PubMed...
  23. Lieberman P. The 10-second rule and other myths about epinephrine and autoinjectors. Ann Allergy Asthma Immunol 2011; 107(3): 189-190. Dostupné z DOI: <http://doi10.1016/j.anai.2011.07.007>. Go to original source... Go to PubMed...
  24. Simons FER, Gu X, Simons KJ. Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J Allergy Clin Immunol 2001; 108(5): 871-873. Dostupné z DOI: <http://10.1067/mai.2001.119409>. Go to original source... Go to PubMed...
  25. Simons F, Ardusso L, Bilo M et al. 2012 Update: World Allergy Organization guidelines for the assessment and management of anaphylaxis. Curr Opin Allergy Clin Immunol 2012; 12(4): 389-399. Dostupné z DOI: <http://dx.doi.org/10.1097/ACI.0b013e328355b7e4>. Go to original source... Go to PubMed...
  26. Lin RY, Curry A, Pesola GR et al. Improved outcomes outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists. Ann Emerg Med 2000; 36(5): 462-468. Dostupné z DOI: <http://dx.doi.org/10.1067/mem.2000.109445>. Go to original source...
  27. Thomas M. Best evidence topic report. Glucagon infusion in refractory anaphylactic shock in patients on beta-blockers. Emerg Med J 2005; 22(4): 272-273. Dostupné z DOI: <http://dx.doi.org/10.1136/emj.2005.023507>. Go to original source... Go to PubMed...
  28. Váchová M., Panzner P. Diagnostika alergie na Hymenopter. Alergie 2017; 19(3): 173-180.
  29. Gagné C. Peanut OIT Therapy Sees Success, Boosting Hope for FDA Approval. Allergic Living: Food Allergy News 2018. Dostupné z WWW: <https://www.allergicliving.com/2018/02/20/peanut-oit-therapy-sees-success-boosting-hope-for-fda-approval/>.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.